clinical_trials
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Confidence92·multiple reportsImportance96NP-EVT-20261110-3C25873
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
Read the original at the primary source
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
11/10/2026, 6:43:04 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —